In our latest "Decoding Exits" episode, Karthik explores how July witnessed strategic consolidation across diverse sectors—from a landmark whiskey brand acquisition to healthcare tech integrations—with deals collectively worth over ₹4,500 crores.
While we typically focus on tech and VC-backed deals, this month brings an interesting twist: Imperial Blue, the world's third-largest whiskey brand by volume, found a new home with an Indian buyer. When a homegrown player like Tilaknagar Industries writes a ₹4,150 crore check to acquire a global brand from Pernod Ricard, it's worth taking note. It's a testament to how Indian companies are not just building brands but also becoming significant players in global M&A.
Here are 6 key insights from July's M&A activity:
- Premium Brands Command Cash: Tilaknagar's ₹4,150 cr cash-heavy deal (95% upfront) for Imperial Blue signals strong appetite for established Indian Made Foreign Liquor (IMFL) brands. With 400k+ outlet reach, the deal illustrates how Indian strategics are willing to pay premium for ready distribution muscle rather than building from scratch.
- B2B Commerce Consolidation 2.0: Udaan ShopKirana's $88.5M all-stock deal at 1-1.3x revenue reflects how larger platforms are absorbing sub-scale players at modest multiples. Stock is preferred over cash as unicorns protect their balance sheets while expanding geographic reach.
- AI Talent Drives Healthcare Exits: Lissun’s acqui-hire of Being Cares (with 2,500+ AI maps) demonstrates how global players are buying Indian AI capabilities and talent. For bootstrapped healthtech startups, strategic acquihires are becoming the preferred exit route versus the challenging path of independent scale.
- PropTech Valuations Reset: Aurum's all-stock acquisition of PropTiger at ~8-9x revenue shows how prop-tech valuations have rationalized. Listed strategics are offering equity-only deals to acquire product-market fit while preserving cash—a trend likely to continue in 2025.
- Regional Scale Through M&A: Dodla's strategic purchase of Osam proves dairy remains a thin-margin, regional play where scale is bought, not built. The focus is on securing milk pools and distribution networks versus paying for brand premium.
- Digital Health Integration Play: Apollo's acquisition of Onco showcases how traditional healthcare giants are absorbing digital-first platforms to strengthen specialty verticals. The deal validates that for VC-backed healthtech startups, strategic M&A with established healthcare chains offers a viable path to scale and sustainability.